Annual Retained Earnings
-$501.34 M
-$151.82 M-43.44%
December 31, 2022
Summary
- As of February 9, 2025, TCRR annual retained earnings is -$501.34 million, with the most recent change of -$151.82 million (-43.44%) on December 31, 2022.
- During the last 3 years, TCRR annual retained earnings has fallen by -$318.75 million (-174.57%).
Performance
TCRR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$541.74 M
-$40.40 M-8.06%
March 31, 2023
Summary
- As of February 9, 2025, TCRR quarterly retained earnings is -$541.74 million, with the most recent change of -$40.40 million (-8.06%) on March 31, 2023.
- Over the past year, TCRR quarterly retained earnings has dropped by -$163.10 million (-43.07%).
Performance
TCRR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TCRR Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.4% | -43.1% |
| 3 y3 years | -174.6% | -173.5% |
| 5 y5 years | -1804.5% | - |
TCRR Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +43.4% | at low | +55.0% | at low |
| 5 y | 5-year | +174.6% | at low | +196.7% | at low |
| alltime | all time | +4119.4% | at low | +1958.0% | at low |
TCR2 Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$541.74 M(+8.1%) |
| Dec 2022 | -$501.34 M(+43.4%) | -$501.34 M(+13.7%) |
| Sep 2022 | - | -$440.84 M(+7.5%) |
| Jun 2022 | - | -$410.25 M(+8.3%) |
| Mar 2022 | - | -$378.64 M(+8.3%) |
| Dec 2021 | -$349.52 M(+40.0%) | -$349.52 M(+8.6%) |
| Sep 2021 | - | -$321.78 M(+8.9%) |
| Jun 2021 | - | -$295.54 M(+9.0%) |
| Mar 2021 | - | -$271.23 M(+8.6%) |
| Dec 2020 | -$249.72 M | -$249.72 M(+8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -$231.26 M(+7.9%) |
| Jun 2020 | - | -$214.34 M(+8.2%) |
| Mar 2020 | - | -$198.10 M(+8.5%) |
| Dec 2019 | -$182.59 M(+113.3%) | -$182.59 M(+7.6%) |
| Sep 2019 | - | -$169.76 M(+8.9%) |
| Jun 2019 | - | -$155.96 M(+7.6%) |
| Mar 2019 | - | -$144.90 M(+69.3%) |
| Dec 2018 | -$85.59 M(+225.1%) | -$85.59 M(+14.1%) |
| Sep 2018 | - | -$75.03 M(+185.0%) |
| Dec 2017 | -$26.32 M(+121.5%) | -$26.32 M |
| Dec 2016 | -$11.88 M | - |
FAQ
- What is TCR2 Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for TCR2 Therapeutics?
- What is TCR2 Therapeutics annual retained earnings year-on-year change?
- What is TCR2 Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for TCR2 Therapeutics?
- What is TCR2 Therapeutics quarterly retained earnings year-on-year change?
What is TCR2 Therapeutics annual retained earnings?
The current annual retained earnings of TCRR is -$501.34 M
What is the all time high annual retained earnings for TCR2 Therapeutics?
TCR2 Therapeutics all-time high annual retained earnings is -$11.88 M
What is TCR2 Therapeutics annual retained earnings year-on-year change?
Over the past year, TCRR annual retained earnings has changed by -$151.82 M (-43.44%)
What is TCR2 Therapeutics quarterly retained earnings?
The current quarterly retained earnings of TCRR is -$541.74 M
What is the all time high quarterly retained earnings for TCR2 Therapeutics?
TCR2 Therapeutics all-time high quarterly retained earnings is -$26.32 M
What is TCR2 Therapeutics quarterly retained earnings year-on-year change?
Over the past year, TCRR quarterly retained earnings has changed by -$163.10 M (-43.07%)